Journal of the American Society of Nephrology (JASN)
American Society of Nephrology
79 episodes
20 hours ago
JASN, the flagship journal of the ASN, publishes basic and clinical science original research articles relevant to the broad discipline of nephrology. The JASN Podcast features discussions with authors of recently published articles. Moderated by the JASN Editor-in-Chief and Deputy Editors, each JASN Podcast episode discusses the latest findings featured in the pages of the journal. Additionally, through the Kidney Translation podcast series, Communications Editor Matt Sparks engages with authors on hot topics across the ASN Journal Portfolio. New episodes are available monthly.
All content for Journal of the American Society of Nephrology (JASN) is the property of American Society of Nephrology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
JASN, the flagship journal of the ASN, publishes basic and clinical science original research articles relevant to the broad discipline of nephrology. The JASN Podcast features discussions with authors of recently published articles. Moderated by the JASN Editor-in-Chief and Deputy Editors, each JASN Podcast episode discusses the latest findings featured in the pages of the journal. Additionally, through the Kidney Translation podcast series, Communications Editor Matt Sparks engages with authors on hot topics across the ASN Journal Portfolio. New episodes are available monthly.
In this ASN Kidney Translation podcast episode, we cover a JASN study on podocyte STAT3 deletion in KLF4 podocytopathy, a CJASN report on early C3G recurrence after transplant, and a Kidney360 study linking foot process effacement to disease progression.
The authors of the ASN Kidney Health Guidance on Potassium and Phosphorus Food additives discuss clinical approaches to managing hyperkalemia and CKD-mineral and bone disorder risks associated with food additives for people with kidney disease.
Drs. Anna Levin and Annika Wernerson discuss the findings from their study, "Transcriptomic Patterns in Adult and Pediatric Patients with IgA Nephropathy or IgA Vasculitis with Nephropathy," with JASN Deputy Editor David H. Ellison.
Drs. Shipra Agrawal and Monoj K. Das discuss the results of their study, "RNA Alternative Splicing and Polyadenylation and Regulation of the Glomerular Filtration Barrier," with JASN Deputy Editor Alan S.L. Yu and Junior Associate Editor Jason O. Wu.
Kidney Translation Podcast discusses cardiovascular and kidney disease studies: CKM syndrome stages and mortality prediction, cardiac risk prediction in patients with kidney failure undergoing noncardiac surgery, and SGLT2 inhibition in type 1 diabetes.
Dr. Ladan Golestaneh discusses the findings of her study, "Effect of Peer Mentorship on Hospitalizations among Patients Receiving Maintenance Hemodialysis: A Pragmatic Randomized Controlled Trial," with JASN Deputy Editor Manjula Kurella Tamura.
Dr. Shaifali Sandal and Saly El Wazze discuss the results of their study, "A Roadmap for Disaster Risk Reduction and Management in Kidney Care: A Scoping Review and Content Analysis," with JASN Deputy Editor Manjula Kurella Tamura.
Drs. David Pearce and John Demko discuss the results of their study, "Coordinated Regulation of Renal Glucose Reabsorption and Gluconeogenesis by mTORC2 and Potassium," with JASN Deputy Editor David H. Ellison.
Dr. Tobias Hermle and Dominik Spitz discuss the findings of their study, "A Drug-Screening Platform for Podocytopathies in Drosophila Nephrocytes," with JASN Deputy Editor Alan S.L. Yu.
On this ASN Kidney Translation Podcast, Dr. Matthew Sparks discusses key ADPKD studies: circadian clock disruption and cyst growth (JASN), depressive symptoms in adults with ADPKD (Kidney360), and biomarker-based kidney outcome prediction (CJASN).
Dr. Ziv Harel discusses findings from his study, "Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial," with JASN Deputy Editor Manjula Kurella Tamura.
Drs. Henrik Dimke and Nina Himmerkus discuss the results of their study, "Calcium-Sensing Receptor in the Thick Ascending Limb and the Renal Response to Hypercalcemia," with JASN Deputy Editor David H. Ellison.
The ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury provides strategies to optimize recovery, implement individualized care, and coordinate best practices in AKI-D management.
In this episode of the ASN Kidney Translation Podcast series, Dr. Matthew Sparks dives into groundbreaking kidney stone research from JASN, CJASN, and Kidney360, exploring CKD risk, asymptomatic stone passage, and how pharmacotherapy affects recurrence.
Drs. Agnès Boutet and Yasmine Lund-Ricard discuss the findings from their study, "Postembryonic Maintenance of Nephron Progenitor Cells with Low Translational Activity in the Chondrichthyan Scyliorhinus canicula," with JASN Deputy Editor David H. Ellison.
Dr. Charles Ginsberg discusses the results of his study, "Acetazolamide Therapy and Kidney Function in Persons with Nonalbuminuric Diabetes Mellitus Type 1," with JASN Deputy Editor Manjula Kurella Tamura.
Drs. Luan D. Truong, Richard J. Johnson, and Gabriela Espinosa Garcia discuss the findings from their study, "Production of Acetylcholine by Podocytes and its Protection from Kidney Injury in Glomerulonephritis," with JASN Deputy Editor Alessia Fornoni.
On this ASN Kidney Translation episode, Dr. Matthew Sparks hosts discussions on nephrology research in genetics. Topics include genetic testing in CKD, ADTKD screening, and digenic Alport syndrome insights.
JASN encourages investigators to submit their basic science original research to the journal. Editor-in-Chief Rajnish Mehrotra and Deputy Editors Alessia Fornoni and David H. Ellison discuss the types of basic research that JASN publishes.
Novel therapies for IgA nephropathy are discussed in this ASN Kidney Translation podcast episode, including efficacy and safety of ravulizumab, selective endothelin receptor antagonist SC0062, and long-term results from a study of atacicept as treatment.
Journal of the American Society of Nephrology (JASN)
JASN, the flagship journal of the ASN, publishes basic and clinical science original research articles relevant to the broad discipline of nephrology. The JASN Podcast features discussions with authors of recently published articles. Moderated by the JASN Editor-in-Chief and Deputy Editors, each JASN Podcast episode discusses the latest findings featured in the pages of the journal. Additionally, through the Kidney Translation podcast series, Communications Editor Matt Sparks engages with authors on hot topics across the ASN Journal Portfolio. New episodes are available monthly.
